Translate this page into:
A Rare Tale of Two Colours: A Sporadic Case of Dyschromatosis Universalis Hereditaria
*Corresponding author: Mishi Joshi, Department of Dermatology, Venereology and Leprosy, Ananta Institute of Medical Sciences, Rajsamand, Rajasthan, India. mishijoshi590@gmail.com
-
Received: ,
Accepted: ,
How to cite this article: Joshi M, Jain M, Parmar P, Sapra P. A Rare Tale of Two Colours: A Sporadic Case of Dyschromatosis Universalis Hereditaria. Indian J Innov Dermatol. 2026;2:38-41. doi: 10.25259/IJID_37_2025
Abstract
Dyschromatosis universalis hereditaria (DUH) is a rare genodermatosis, typically inherited in an autosomal dominant pattern, though autosomal recessive inheritance has also been reported. It belongs to the group of reticulate pigmentary disorders and is characterised by the presence of both hyperpigmented and hypopigmented macules distributed symmetrically across the body, particularly involving the dorsal aspects of the extremities, face, and trunk. We report a rare sporadic case of DUH in a 14-year-old boy who presented with multiple small, non-progressive dyschromic macules on the dorsal surfaces of the upper and lower extremities, face, trunk, and oral mucosa. No neurological abnormalities were noted, and family history was non-contributory. The diagnosis was confirmed based on clinical evaluation and histopathological findings, which revealed basal layer hypermelanosis and the presence of melanophages in the superficial dermis within hyperpigmented lesions.
Keywords
Dyschromatosis universalis hereditaria
Genodermatosis
Hyperpigmentation
Hypopigmentation
Pigmentary disorders
INTRODUCTION
Dyschromatosis universalis hereditaria (DUH) is an uncommon reticular pigmentary disorder characterised by symmetrical hyperpigmented and hypopigmented macules, often distributed over the trunk and extremities. First reported in Japan, DUH has since been recognised globally, including in India.[1-3] While typically inherited in an autosomal dominant pattern, autosomal recessive and sporadic variants have also been described. The condition is usually benign, with limited treatment options, although recent genetic studies and laser therapies have shown potential.[4]
CASE REPORT
A 14-year-old male presented with asymptomatic, well-defined reticular hypopigmented and hyperpigmented macules since the age of three years. Lesions began on the face and gradually spread to the limbs and trunk. No history of consanguinity, photosensitivity, pruritus, or systemic symptoms was noted. No history of prolonged drug intake and exposure to any chemicals was present. Family history was not significant, and birth history revealed a normal delivery with low birth weight. He was small-statured and underweight, with a height of 135 cm (<3rd centile) and a weight of 23.5 kg (<3rd centile for age).
Cutaneous examination revealed multiple symmetrical reticular hypopigmented and hyperpigmented macules and patches over cheeks, nose, chin, ears [Figure 1], eyelids, arms [Figure 2], dorsum of hands, thighs, legs, and feet, with relative sparing of the trunk [Figure 3]. These macules did not have any atrophy, scaling, or telangiectasia. Lateral superciliary madarosis was present bilaterally.



The gingival, labial, and buccal mucosa showed hyperpigmentation [Figure 4]. Palms and soles were completely spared. Nails, teeth, and hair were normal. No abnormality was detected on neurological and ophthalmological examination.

Routine investigations, including complete blood counts, liver function tests, renal function tests, and urinalysis, were within normal limits.
Various sections and deeper cuts of the H&E-stained slide were studied. The Fontana-Masson stain was not used due to unavailability.
Hyperpigmented macule (over left leg) showed hyperkeratosis with increased basal pigmentation and melanophages in dermis.
Hypopigmented macule (over left forearm) showed orthokeratosis, spongiosis, reduced basal pigmentation, and superficial perivascular lymphocytes [Figure 5].

These findings confirmed DUH. Differential diagnoses such as dyschromatosis symmetrica hereditaria (DSH), vitiligo, and xeroderma pigmentosum were ruled out based on distribution, mucosal involvement, and histopathology. The patient was counselled and advised regarding sun protection and emollients. No active treatment was initiated.
DISCUSSION
DUH is a rare genodermatosis presenting in early childhood with mottled hyper- and hypopigmented macules, typically inherited in autosomal dominant or recessive patterns.[1,2,5] Our case represents a rarely described sporadic form with unusual mucosal pigmentation and lateral madarosis.[6] The absence of systemic findings and photosensitivity, along with normal neurological and ophthalmological evaluation, helped rule out other pigmentary disorders such as xeroderma pigmentosum and Aicardi-Goutières syndrome.
Histopathology showed typical features, including basal hypermelanosis and dermal melanophages.[3,6,7]
Mutations in ATP binding cassette subfamily B member 6 (ABCB6) and sterile alpha motif and Src homology (SH3) domain-containing protein 1 (SASH1) contribute to its genetic basis, highlighting heterogeneity.[4,8] Although genetic testing was not performed, clinical and histological findings were consistent with the diagnosis of DUH. Our patient showed generalised involvement and mucosal changes, further supporting the diagnosis. DUH must be differentiated from amyloidosis cutis dyschromica and DSH, which has an acral pattern and adenosine deaminase acting on RNA 1 (ADAR1) mutation.[9]
Management remains supportive. Cosmetic counselling and photoprotection are key. Picosecond laser therapy has shown promise in selected genetic variants,[4] though it is not widely accessible.
CONCLUSION
This case highlights a sporadic occurrence of DUH in an adolescent male, emphasising the need for awareness of its clinical and histopathological features for accurate diagnosis. Early recognition can prevent unnecessary interventions and provide reassurance to patients and families.
Ethical approval:
Institutional Review Board approval is not required.
Declaration of patient consent:
The authors certify that they have obtained all appropriate patient consent forms. In the form, the patients have given their consent for their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Conflicts of interest:
There are no conflicts of interest.
Use of artificial intelligence (AI)-assisted technology for manuscript preparation:
The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.
Financial support and sponsorship: Nil.
References
- Ultrastructural investigations in an autosomal recessively inherited case of dyschromatosis universalis hereditaria. Acta Derm Venereol. 2015;95:738-40.
- [CrossRef] [PubMed] [Google Scholar]
- Dyschromatosis universalis hereditaria: Report of six cases from a family. Dermatol Online J. 2016;22:13030/qt24p9j62b.
- [CrossRef] [PubMed] [Google Scholar]
- Dyschromias: A series of five interesting cases from India. Indian J Dermatol. 2015;60:636.
- [CrossRef] [PubMed] [Google Scholar]
- Dyschromatosis universalis hereditaria with SASH1 mutation improved with picosecond laser treatment. Skin Health Dis. 2025;5:191-5.
- [CrossRef] [PubMed] [Google Scholar]
- Dyschromatosis universalis hereditaria: Infrequent genodermatoses in India. Indian J Hum Genet. 2013;19:487-90.
- [CrossRef] [PubMed] [Google Scholar]
- Dyschromatosis universalis hereditaria with involvement of palms. Indian Dermatol Online J. 2014;5:296-9.
- [CrossRef] [PubMed] [Google Scholar]
- Dyschromatosis universalis hereditaria. Kathmandu Univ Med J. 2021;19:146-7.
- [CrossRef] [Google Scholar]
- Mutations in ABCB6 cause dyschromatosis universalis hereditaria. J Invest Dermatol. 2013;133:2221-8.
- [CrossRef] [PubMed] [Google Scholar]
- Dyschromatosis symmetrica hereditaria may be successfully controlled by topical sunscreen. Eur J Dermatol. 2018;28:840-1.
- [CrossRef] [PubMed] [Google Scholar]
